دورية أكاديمية
A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland
| العنوان: | A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland |
|---|---|
| المؤلفون: | Panje, C.M., Lupatsch, J.E., Barbier, M., Pardo, E., Lorez, M., Dedes, K.J., Aebersold, D.M., Plasswilm, L., Gautschi, O., Schwenkglenks, M. |
| المصدر: | In Annals of Oncology April 2020 31(4):501-506 |
| قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!